Measurements of the Cosmic-Ray Positron Fraction From 1 to 50 GeV

Autor: HEAT Collaboration, Barwick, S. W., Schneider, E., Beatty, J. J., de Nolfo, G. A., Bhattacharyya, A., Bower, C. R., Musser, J. A., Chaput, C. J., Coutu, S., McKee, S., Tarle, G., Tomasch, A. D., Knapp, J., Lowder, D. M., Muller, D., Swordy, S. P., Torbet, E., Nutter, S. L.

Publikováno v: Astrophys.J. 482 (1997) L191-L194

Two measurements of the cosmic-ray positron fraction as a function of energy have been made using the High Energy Antimatter Telescope (HEAT) balloon-borne instrument. The first flight took place from Ft. Sumner, New Mexico in 1994, and yielded resul

Externí odkaz: http://arxiv.org/abs/astro-ph/9703192

The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response.

Autor: Berchuck JE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Adib E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Abou Alaiwi S; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Dash AK; Department of Medicine, Baylor College of Medicine, Houston, Texas., Shin JN; Department of Medicine, Baylor College of Medicine, Houston, Texas., Lowder D; Department of Medicine, Baylor College of Medicine, Houston, Texas., McColl C; Department of Medicine, Baylor College of Medicine, Houston, Texas., Castro P; Department of Pathology, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, Texas., Carelli R; Avera Institute for Human Genetics, Sioux Falls, South Dakota., Benedetti E; Avera Institute for Human Genetics, Sioux Falls, South Dakota., Deng J; Department of Medicine, Baylor College of Medicine, Houston, Texas., Robertson M; Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, Texas., Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Bell C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., McClure HM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., El Zarif T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Davidsohn MP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Lakshminarayanan G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Rizwan K; Department of Medicine, Baylor College of Medicine, Houston, Texas., Skapura DG; Department of Medicine, Baylor College of Medicine, Houston, Texas., Grimm SL; Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, Texas., Davis CM; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York., Ehli EA; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York., Kelleher KM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Mitsiades N; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Coarfa C; Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas., Pomerantz MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Loda M; Avera Institute for Human Genetics, Sioux Falls, South Dakota., Ittmann M; Department of Pathology, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, Texas., Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts., Kaochar S; Department of Medicine, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.

Publikováno v: Cancer research [Cancer Res] 2022 Aug 16; Vol. 82 (16), pp. 2848-2859.

The AMANDA Neutrino Detector

Autor: Wischnewski, R., Andrés, E., Askebjer, P., Barwick, S., Bay, R., Bergström, L., Biron, A., Booth, J., Botner, O., Bouchta, A., Carius, S., Carlson, M., Chinowsky, W., Chirkin, D., Cowen, D., Costa, C., Dalberg, E., Deyoung, T., Edsjo, J., Ekström, P., Goobar, A., Gray, L., Hallgren, A., Halzen, F., Hardtke, R., He, Y., Hill, G., Hulth, P., Hundertmark, S., Jacobsen, J., Kandhadai, V., Karle, A., Kim, J., Leich, H., Leuthold, M., Lindahl, P., Liss, T., Liubarsky, I., Loaiza, P., Lowder, D., Marciniewski, P., Miller, T., Miocinovic, P., Mock, P., Morse, R., Newcomer, M., Niessen, P., Nygren, D., Pérez de los Heros, C., Porrata, R., Price, P., Przybylski, G., Rhode, W., Richter, S., Rodriguez, J., Romenesko, P., Ross, D., Rubinstein, H., Schmidt, T., Schneider, E., Schwarz, R., Schwendicke, U., Smoot, G., Solarz, M., Sorin, V., Spiering, C., Steffen, P., Stokstad, R., Streicher, O., Thollander, L., Thon, T., Tilav, S., Walck, C., Wiebusch, C., Woschnagg, K., Wu, W., Yodh, G., Young, S.

Publikováno v: In Nuclear Physics B (Proceedings Supplements) 1999 75(1):412-414

Quantitative Multi-Parametric MRI of the Prostate Reveals Racial Differences.

Autor: Chatterjee, Aritrick^1,2 (AUTHOR) aritrick@uchicago.edu, Fan, Xiaobing¹ (AUTHOR) ayousuf@uchicagomedicine.org, Slear, Jessica¹ (AUTHOR) mmedved@uchicago.edu, Asare, Gregory¹ (AUTHOR) gskarczm@uchicago.edu, Yousuf, Ambereen N.^1,2 (AUTHOR) aoto@bsd.uchicago.edu, Medved, Milica^1,2 (AUTHOR), Antic, Tatjana³ (AUTHOR) tatjana.antic@bsd.uchicago.edu, Eggener, Scott⁴ (AUTHOR) seggener@bsd.uchicago.edu, Karczmar, Gregory S.^1,2 (AUTHOR), Oto, Aytekin^1,2 (AUTHOR)

Publikováno v: Cancers. Oct2024, Vol. 16 Issue 20, p3499. 13p.

Involvement of Reactive Oxygen Species in Prostate Cancer and Its Disparity in African Descendants.

Autor: Liou, Geou-Yarh^1,2 (AUTHOR) gliou@cau.edu, C'lay-Pettis, Reauxqkwuanzyiia¹ (AUTHOR), Kavuri, Sravankumar³ (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Jun2024, Vol. 25 Issue 12, p6665. 13p.